Arcturus Therapeutics Holdings Inc Cash Flow Statement

ARCT $42.96 -0.2 -0.5%

9:00pm

Speculative, Mid Cap, Sucker Stock

Market Cap £820.1m

Enterprise Value £496.5m

Revenue £6.89m

Quality

Value

Momentum

StockRank™

To unlock Arcturus Therapeutics Holdings Inc's cashflow statement please upgrade your membership.

	2015	2016	2017	2018	2019	2020
Period End:	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31
Period Length:	12M	12M	12M	12M	12M	12M
Currency:	USD	USD	USD	USD	USD	USD

Net Income/Starting Line

Depreciation/Depletion
Non-Cash Items
Unusual Items
Equity in Net Earnings (Loss)
Other Non-Cash Items
Changes in Working Capital
Accounts Receivable
Prepaid Expenses
Other Assets
Accounts Payable
Accrued Expenses
Other Liabilities
Cash from Operating Activities

Capital Expenditures
Purchase of Fixed Assets
Other Investing Cash Flow Items, Total
Sale of Fixed Assets
Sale/Maturity of Investment
Investment, Net
Purchase of Investments
Cash from Investing Activities

Issuance (Retirement) of Stock, Net
Issuance (Retirement) of Debt, Net
Cash from Financing Activities

Net Change in Cash
Starting Cash Balance
Ending Cash Balance

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.